tiprankstipranks
OKYO Pharma (GB:OKYO)
LSE:OKYO

OKYO Pharma (OKYO) Share Price & Analysis

1 Followers

OKYO Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range1.35p - 8.50p
Previous Close1.4p
Volume0.00
Average Volume (3M)359.72K
Market Cap
2.44B
Enterprise Value2.38B
Total Cash (Recent Filing)£633.63K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)N/A
Beta-0.03
Aug 01, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,415,040,468
10 Day Avg. Volume597,781
30 Day Avg. Volume359,719
Standard Deviation17.80
R-Squared0.02
Alpha2.72
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

OKYO FAQ

What was OKYO Pharma’s price range in the past 12 months?
OKYO Pharma lowest share price was 1.35p and its highest was 8.50p in the past 12 months.
    What is OKYO Pharma’s market cap?
    Currently, no data Available
    When is OKYO Pharma’s upcoming earnings report date?
    OKYO Pharma’s upcoming earnings report date is Aug 01, 2023 which is 270 days ago.
      How were OKYO Pharma’s earnings last quarter?
      OKYO Pharma released its earnings results on Dec 30, 2022. The company reported 0p earnings per share for the quarter, the consensus estimate of N/A by 0p.
        Is OKYO Pharma overvalued?
        According to Wall Street analysts OKYO Pharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does OKYO Pharma pay dividends?
          OKYO Pharma does not currently pay dividends.
          What is OKYO Pharma’s EPS estimate?
          OKYO Pharma’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does OKYO Pharma have?
          OKYO Pharma has 1,658,792,400 shares outstanding.
            What happened to OKYO Pharma’s price movement after its last earnings report?
            OKYO Pharma reported an EPS of 0p in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -9.091%.
              Which hedge fund is a major shareholder of OKYO Pharma?
              Currently, no hedge funds are holding shares in GB:OKYO
              ---

              OKYO Pharma Stock Smart Score

              Company Description

              OKYO Pharma

              OKYO Pharma Ltd is a life science and biotechnology company. The company is focusing on opportunities where clinical development timeliness is short to generate incremental value for shareholders. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              OKYO Pharma
              Aurinia Pharmaceuticals
              BioCryst
              Evolus
              Fennec Pharmaceuticals
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis